论文部分内容阅读
本文通过三种6个月方案的严密对照研究,证明2R_3H_3Z_3/4R_3H_3在不住院条件下采用全监化疗组织管理措施完全可行,其痰菌阴转率96.3%,1年细菌学复发率1.9%,且副反应少。
In this paper, a close control study of three 6-month regimens shows that 2R_3H_3Z_3 / 4R_3H_3 is feasible and feasible in the treatment of non-hospitalized patients. The sputum negative conversion rate is 96.3%, the 1-year bacteriological recurrence rate is 1.9% And less side effects.